异常的SWI/SNF复合体成员在罕见的卵巢恶性瘤中占主导地位 - - 治疗耐药亚型中的治疗脆弱性
Yue Ma1, Natisha R Field1, Tao Xie1
1Translational Oncology Group, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW 2007, Australia.
Cancers
|September 14, 2024
概括
SWI/SNF复合体中的突变在卵巢癌,如OCCC和SCCOHT中很常见. 针对这些SWI/SNF通路改变,为这些罕见的癌症提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- SWI/SNF (Switch/Sucrose Non-Fermentable) 复合体在人类癌症中经常发生变化,特别是在罕见的卵巢癌亚型中.
- 特定的SWI/SNF亚单元突变的特征是耐化学反应的卵巢清细胞癌 (OCCC) 和卵巢小细胞癌,高血型 (SCCOHT).
- 在ARID1A的体性突变在OCCC (42-67%) 和子宫内膜卵巢癌 (EnOC) 中普遍存在,并且在子宫内膜异位症中也被发现,这表明它起着前体作用.
研究的目的:
- 研究SWI/SNF复杂突变在特定卵巢癌亚型中的作用.
- 要突出在OCCC和SCCOHT中的ARID1A,SMARCA4和SMARCA2中的遗传变化.
- 探索因SWI/SNF通路失调而产生的潜在的治疗漏洞.
主要方法:
- 在卵巢癌基因病理亚型中对SWI/SNF复合体成员的体突变进行分析.
- 检查ARID1A,ARID1B,SMARCA4和SMARCA2突变以及表观遗传沉默.
- 对卵巢癌和子宫内膜异位症中的SWI/SNF突变现有文献的综述.
主要成果:
- 在OCCC和EnOC中,ARID1A突变很常见,在子宫内膜异位症中也存在.
- SMARCA4突变 (69-100%) 和SMARCA2沉默 (86-100%) 是SCCOHT的特征.
- 在这些卵巢癌中,ARID1B,SMARCA2,SMARCB1和SMARCC1的突变较少见.
结论:
- SWI/SNF复杂突变是特定卵巢癌亚型的关键驱动因素,包括OCCC和SCCOHT.
- 了解这些遗传变化,可以了解子宫内膜异位症相关的卵巢癌的发病过程.
- SWI/SNF通路的失调提供了治疗机会,包括使用DNA损伤修复抑制剂,表观遗传修饰剂和免疫检查点封锁.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K


